Abstract
Introduction
Multiple sclerosis (MS) is a central nervous system disease characterized by demyelination. Although the precise etiology of MS is not known, it has been reported that genetic, environmental, and geographical factors may be causative (1) (2) (3) . Recently, studies showed an association between vitamin D levels and high risk for autoimmune diseases such as systemic lupus erythematosus and MS. Some studies have determined a correlation between MS risk and serum vitamin D levels. In addition, there is a positive correlation between serum vitamin D level and Vitamin D receptor (VDR) (3) (4) (5) (6) (7) .
The primary form of vitamin D, colecalciferol (vitamin D 3 ), is synthesized in the skin upon exposure to ultraviolet radiation (UVR). This form of vitamin D is enzymatically converted in the liver to 25-hydroxyvitamin D (25(OH) D), which is regulated by the vitamin D receptor (VDR). The mechanism underlying the correlation between vitamin D and autoimmunity is the immunomodulatory function of vitamin D as well as the presence of the VDR on the most immune cells. Impaired vitamin D signaling, inadequate vitamin D intake, and/or environmental factors (e.g. insufficient sunlight exposure) may contribute to the onset and progression of autoimmunity in MS patients (1, 2, 4) .
The vitamin D receptor gene (VDRG) is mapped to chromosome 12q (12-12q14). Although more than 30 polymorphisms in the VDR gene have been identified, ApaI (rs7975232), BsmI (rs 1544410), and TaqI (rs731236) are the most widely studied. These single nucleotide polymorphisms (SNPs) are located close to the 3' terminus of the gene and do not result in structural changes in the VDR protein (5) (6) (7) .
Previous studies have shown that the VDR gene may be a significant predictor of MS; however, the results have been inadequate. The relationship between polymorphisms in the VDR gene and the risk of MS were determined in different studies (4, 11, 12) .
The aim of this study was to evaluate VDR ApaI (rs7975232), BsmI (rs1544410), and TaqI (rs731236) alleles and genotypes in MS patients in comparison with controls.
Materials and Methods

Study population
The study was planned as a case-control study. The MS population was obtained from patients in university hospitals in Canakkale Onsekiz Mart, Turkey, and the diagnosis was made by a neurologist according to the Revised McDonald Criteria (8) . Approval for the study was obtained from the Ethics Committee of Canakkale University Faculty of Medicine. Peripheral venous blood samples were collected from 70 patients with MS and from 70 age-and gender-matched healthy controls.
Genetic analaysis
DNA was isolated from blood samples using AccuPrep Genomic DNA extraction kits (Bioneer, Daejeon, South Korea). DNA purity and quantity were assessed by absorbance values using a spectrophotometer (DeNovix DS-11+, Thermo Scientific, USA).
To amplify a 740 bp fragment of the ApaI (rs7975232) polymorphism, the following primers were used: 5′CTGCCGTTGAGTGTCTGT-GT3′ (forward) and 5′TCGGCTAGCTTCT-GGATCAT3′ (reverse). Amplification was performed in a final volume of 50 μL reaction mixture containing 200 μM of dNTPs, 10 pmol each of forward (F) and reverse (R) primers, 1 U HotStarTaq DNA polymerase (Bioneer), 1× PCR buffer (Bioneer), and 100 ng genomic DNA. The thermal profile was as follows: an initial denaturation step at 95°C for 5 min, followed by 35 cycles of 94°C for 30 s, 65°C for 30 s, 72°C for 30 s, and final extension step at 72°C for 2 min. Then, the PCR products (740 bp) were digested at 25°C for 2 h with 5.0 U of ApaI (Thermo Fisher Scientific), and electrophoresed on a 2% agarose gel stained with ethidium bromide. Digestion of the PCR product by ApaI yields 740 bp for AA, 520/220 bp for aa, and 740/520/220 bp bands for Aa genotypes.
The BsmI (rs1544410) polymorphism was genotyped by PCR-RFLP. The primers used were 5′GGGAGACGTAGCAAAAGGAG3′ (forward) and 5′CCATCTCTCAGGCTC-CAAAG3′ (reverse). Amplification was accomplished with a 50 µL reaction mixture containing 100 ng template DNA, 10 pmol each of forward (F) and reverse (R) primers, 0.2 mM each dNTP, 1 U HotStarTaq DNA polymerase (Bioneer), and 1× PCR buffer (Bioneer). The PCR profile consisted of an initial denaturation at 94°C for 5 minutes, followed by 35 cycles of denaturation (30 seconds), annealing temperature (94°C, 56°C and 72°C, respectively, 50 seconds) and extension (72°C, 2 minutes). Then, the amplified PCR products (191 bp) were cleaved with 5.0 U of BsmI (Thermo Fisher Scientific) and electrophoresed on a 3% agarose gel stained with ethidium bromide. Digestion of the PCR product by BsmI yields 191 bp for BB, 115/76 bp for bb and 191/115/76 bp for Bb genotypes.
The primers designed for both ends of the TaqI (rs731236) polymorphism allele were 5′CCCATGAAGCTTAGGAGGAA3′ (forward) and 5′TCATCTTGGCATAGAGCAGGT3′ (reverse). PCR was achieved in a 50 μL volume containing 100 ng of template DNA, 1 U HotStarTaq DNA polymerase (Bioneer), 1× PCR buffer (Bioneer), and 10 pmol of each primer. The reaction conditions consisted of an initial melting step at 95°C for 5 min, followed by 35 cycles of 94°C for 45 s, 72°C for 45 s, 72°C for 30 s; and final extension step at 72°C for 2 min. Then, the PCR products (740 bp) were digested at 25°C for 2 h with 5.0 U of TaqI (Thermo Fisher Scientific) and electrophoresed on a 2% agarose gel stained with ethidium bromide. Digestion of the PCR product by TaqI yields 495/45 bp for TT, 290/245/205 bp for tt, and 495/290/245/205bp for Tt genotypes.
Statistical analysis
Statistical analysis was performed using SPSS version 19.0. (SPSS, IBM Company). Kolmogorov-Smirnov test was used to assess the normality of data distribution. Normally distributed data are reported as mean±standard deviation. Genotype frequencies were tested on Hardy-Weinberg equilibrium with the χ 2 test. A statistical difference was considered significant when the p-value was less than 0.05. The associations between these genotypes and the risk of MS were estimated by computing the odds ratios (ORs) and their 95% confidence intervals (CIs) from binary logistic regression analysis.
Results
The study population comprised 70 unrelated patients (19 males and 51 females; mean age=44.4±11.2 years) with a clinical diagnosis of MS recruited consecutively and prospectively from those who were treated and followed-up in the Neurology Department of Canakkale Onsekiz Mart University Research Hospital, Çanak-kale, Turkey. Of the MS group, 47 patients had relapsing-remitting MS (RRMS), 14 patients had secondary progressive MS (SPMS), and 9 patients had primary progressive MS (PPMS). A total of 70 unrelated healthy subjects (22 males and 48 females; mean age=38.2±9.5 years) were recruited consecutively. The healthy controls were matched for age and gender with MS patients (Table 1) .
For both cases and controls, the distribution frequency of each genotype and allele is summarized in Table 2 . The frequencies of aa, Aa and AA genotypes were 21.4, 38.6 and 40.0% in the patient group and 41.4, 30.0 and 28.6% in the control group, respectively. There was a statistically significant difference in the frequencies of genotypes between patient and control groups (p=0.04, ref (aa); OR: 2.49 , CI: 1.07-5.79, (Aa); CI: 2.71, OR: 1.16-6.32 (AA)). The A allele of ApaI polymorphism was more frequent in cases than in controls (59.3%, and 43.6%, respectively) (p=0.01). The BsmI and TaqI polymorphisms were not significantly different in the frequencies of genotypes between patient and control groups. There was not a statistically significant difference in the distribution of the VDR genotypes in the disease course of MS patients (Table 3) . (1, 2, 4, 6, (9) (10) (11) (12) .
Our study shows no association of the specific VDR gene polymorphisms BsmI and TaqI in MS.
In previous studies, the association between VDR gene polymorphisms and MS was investigated in several populations (11, 13, 14) . Our results are consistent with some studies reported in the literature for various populations. A study in Iran reported that there was a significant difference in genotype distribution between case and control groups for polymorphism and allelic frequency for ApaI, BsmI and TaqI (15) . A Japanese group found a higher frequency of the ApaI AA genotype and A allele in MS (16). Sioka et al. showed no association of the ApaI, BsmI and TaqI polymorphisms of the VDR gene (17) . The work of Abdollahzadeh et al. was similar to the study by the Japanese group (15) . The results of our study are consistent with those found by Sioka and colleagues; in addition, our ApaI A allele frequency findings are compatible with the Japanese group and Abdollahzadeh (15) (16) (17) .
Bermúdez-Morales et al. found a positive association of the genetic polymorphisms of VDR, specifically TaqI (rs731236) and BsmI (rs1544410). They suggested that more epidemiological and genetic studies are necessary (10) .
One limitation of our study is that vitamin D status was not determined. However, another case-control study of MS in a similar population showed no differences in serum (25(OH)D) concentrations between cases and controls (22.3+6.4 ng/mL and 23.3+6.3 ng/mL, respectively), indicating no association between vitamin D status and MS risk in Mexican adults (5, 10) .
Thus far, VDR has been investigated in many studies to determine the relationship with MS, but there are contradictory conclusions (12, (18) (19) (20) . Small sample sizes, low statistical power, differences in ethnicities, extensive geographic variation, interactions with other genetic or environmental factors, and/or clinical heterogeneity may be the reasons for this disparity.
In summary, this study suggests that the ApaI polymorphisms of the VDR gene may be associated with MS risk. 
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